BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38232462)

  • 1. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.
    Chen X; Luo Z; Hu Z; Sun D; He Y; Lu J; Chen L; Liu S
    Eur J Med Chem; 2024 Feb; 266():116082. PubMed ID: 38232462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 2-phenyl-3-(Pyridin-2-yl) thiazolidin-4-one derivatives as potent inhibitors for proliferation of osteosarcoma cells in vitro and in vivo.
    Deng Y; Pi R; Niu L; Zhao Y; Ni D; Song L; Li Z; Han W; Wei Q; Han Y; Zhu T; Luo Z; Sun D; Dong S; Liu S
    Eur J Med Chem; 2022 Jan; 228():114010. PubMed ID: 34861640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.
    Chen X; Liu L; Liu P; Chen Y; Lin D; Yan H; Yan Q; Wang Y; Qiu Y; Fang B; Huang H; Qian J; Zhao Y; Du Z; Zhang Q; Li X; Zheng X; Liu Z
    J Med Chem; 2022 Apr; 65(7):5374-5391. PubMed ID: 35239349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma.
    Reddy GB; Kerr DL; Spasojevic I; Tovmasyan A; Hsu DS; Brigman BE; Somarelli JA; Needham D; Eward WC
    Mol Cancer Ther; 2020 Jul; 19(7):1448-1461. PubMed ID: 32371588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
    Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
    Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
    Shi JJ; Jia KH; Sun H; Gunosewoyo H; Yang F; Tang J; Luo J; Yu LF
    ChemMedChem; 2021 Feb; 16(3):524-536. PubMed ID: 32964625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
    Igarashi K; Kawaguchi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Higuchi T; Taniguchi Y; Yonezawa H; Araki Y; Morinaga S; Misra S; Nelson SD; Dry SM; Li Y; Odani A; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(3):217-223. PubMed ID: 32345663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteosarcoma Patient-derived Orthotopic Xenograft (PDOX) Models Used to Identify Novel and Effective Therapeutics: A Review.
    Higuchi T; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Bouvet M; Tsuchiya H; Hoffman RM
    Anticancer Res; 2021 Dec; 41(12):5865-5871. PubMed ID: 34848441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aurothiomalate treatment on canine osteosarcoma in a murine xenograft model.
    Scharf VF; Farese JP; Siemann DW; Abbott JR; Kiupel M; Salute ME; Milner RJ
    Anticancer Drugs; 2014 Mar; 25(3):332-9. PubMed ID: 24304691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proscillaridin A induces apoptosis and inhibits the metastasis of osteosarcoma in vitro and in vivo.
    Fang S; Tao H; Xia K; Guo W
    Biochem Biophys Res Commun; 2020 Jan; 521(4):880-886. PubMed ID: 31708095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetastatic activity of honokiol in osteosarcoma.
    Steinmann P; Walters DK; Arlt MJ; Banke IJ; Ziegler U; Langsam B; Arbiser J; Muff R; Born W; Fuchs B
    Cancer; 2012 Apr; 118(8):2117-27. PubMed ID: 21935912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models.
    Ruiz MC; Resasco A; Di Virgilio AL; Ayala M; Cavaco I; Cabrera S; Aleman J; León IE
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):681-692. PubMed ID: 30661096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
    Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
    Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic Effects of Castalin Nanoparticles Against Osteosarcoma.
    Zhang S; Ren H; Sun HT; Cao S
    Appl Biochem Biotechnol; 2023 Sep; 195(9):5355-5364. PubMed ID: 35226253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of casein kinase 2 prevents growth of human osteosarcoma.
    Takahashi K; Setoguchi T; Tsuru A; Saitoh Y; Nagano S; Ishidou Y; Maeda S; Furukawa T; Komiya S
    Oncol Rep; 2017 Feb; 37(2):1141-1147. PubMed ID: 27959425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
    Wang Y; Fu Q; Zhao W
    Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine citrate enhanced cisplatin antitumor effects in osteosarcoma and fibrosarcoma in vitro and in vivo.
    Abe K; Yamamoto N; Hayashi K; Takeuchi A; Tsuchiya H
    BMC Cancer; 2019 Jul; 19(1):689. PubMed ID: 31307409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.